J Diabetes Investig 1(12):823 Sesti G, Avogaro A, Belcastro S, Bonora BM, Croci M, Daniele G et al (2019) Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus
Being able to speak to it accurately including its limitations and its unapproved status is part of practicing responsibly in anti-aging and regenerative medicine
A., Wharton, S., Yokote, K., & Kraus, W
Key groups who benefit most from IV therapy include: Individuals with nutritional deficiencies: People who lack essential vitamins and minerals due to poor diet, digestive issues, or certain medical conditions may find IV therapy effective for restoring balance
AJ was supported by a grant from Fondation pour la Recherche Mdicale (FDT202304016501) and LR is supported by a doctoral grant from the French Ministry of Research